Scholars Central

Editor

Angelica Merlot

Molecular Pharmacology and Pathology, The University of Sydney, Australia, Faculty of Medicine

About

As published by the journal they serve.

Dr. Angelica Merlot is a Postdoctoral Research Associate in the Pathology Department of the University of Sydney. She heads the Cancer Therapeutics Group within the Molecular Pharmacology and Pathology Program. During her PhD, she investigated the pharmacological mechanisms of action and membrane transport of anti-cancer thiosemicarbazones. The most potent agent of this class is entering clinical trials in 2016. Angelica is interested in improving the targeting and pharmacological complications of cancer therapies that cause toxicity and drug resistance. Her current research focuses on the characterization of the endoplasmic reticulum stress pathways in cancer and modulating these signals to induce cancer cell death and inhibit metastasis.

Research interests

  • Oncology
  • Drug Delivery
  • Albumin
  • ER Stress
  • Endocytosis
  • Metastasis
  • Cell Biology
  • Membrane Transport
  • Cancer Cell Biology
  • Iron Metabolism
  • Chemotherapy
  • Molecular Biology

Journals they serve

The seats these journals name them in.

Articles we hold

Articles in the journals they serve whose byline carries this name.

This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.